drugset
drugset / Trial / NCT04676685

A Study to Assess the Safety and Tolerability of E2730 After Multiple Dose and the Food Effect After Single Dose in Healthy Participants

NCT04676685 ↗

Phase 1 Completed 32 enrolled Eisai Inc.
RandomizedParallel-groupTriple-blindOther

Summary

The primary purpose of the study is to evaluate the safety, tolerability, and pharmacokinetics (PK) of E2730 of multiple ascending oral doses in healthy adult participants and to assess the differences in PK, safety, and tolerability of E2730 between healthy Japanese and non-Japanese participants following multiple doses. This study will also determine the effect of food on PK of E2730.

Timeline

Start
2020-12-16
Primary completion
2021-06-23
Completion
2021-06-23

Drugs

EvaluationDrugModalityDoseRoute
Subject E2730 Unknown 20 mg Oral
Subject E2730 Unknown 40 mg Oral
Subject E2730 Unknown 60 mg Oral
Subject E2730 Unknown 80 mg Oral

Indications

No indication recorded.